Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT ...

Please provide your email address to receive an email when new articles are posted on . Fluorodeoxyglucose PET-CT scans with pretest diet preparation detected extra-thoracic sarcoid in patients with ...

Many people who experience chest pain but don't have a heart attack breathe a big sigh of relief when a stress test comes back negative for blockages in their blood vessels. But a new study by cardiac ...

Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests, researchers have found that the disease affects other organs in 40 percent of patients ...

Karin Rexroad peeks through the bore of the PET-CT scanner at LMH Health. Positron emission tomography, or PET, scans have long been used to diagnose cancer and determine how far it has progressed.

HOUSTON – (Not for use before July 3, 2007) -- Current PET-CT scanners with standard commercial software designed to provide images of the heart are falsely indicating coronary artery disease in as ...

Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical ...

Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT ...